EBITDA: Income before interest, taxes, depreciation and amortization.
Pulmonx Corporation (LUNG) had EBITDA of $-14.62M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$23.86M |
|
$-15.17M |
|
$6.66M |
|
$17.20M |
|
$38.66M |
|
$-14.80M |
|
$-0.19M |
|
$-15.00M |
|
$-15.00M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-15.17M |
|
$-14.80M |
|
|
EBITDA |
$-14.62M |
40.43M |
|
40.43M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$120.02M |
|
$2.66M |
|
$27.17M |
|
$147.19M |
|
$22.45M |
|
$37.01M |
|
$55.65M |
|
$78.10M |
|
$69.09M |
|
$66.76M |
|
$69.09M |
|
40.74M |
|
| Cash Flow Statement Financials | |
$-17.13M |
|
$21.78M |
|
$0.60M |
|
$71.16M |
|
$75.72M |
|
$4.56M |
|
$11.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.35 |
|
-- |
|
-- |
|
0.35 |
|
0.54 |
|
72.11% |
|
-62.05% |
|
-62.05% |
|
-- |
|
-62.85% |
|
-63.59% |
|
$-17.48M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.41 |
|
1.50 |
|
59.99 |
|
-21.96% |
|
-22.73% |
|
-10.31% |
|
-14.30% |
|
$1.70 |
|
$-0.43 |
|
$-0.42 |
|